Skip to main content
OpenTrials
Completed

NCT Number: NCT04934904

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

In this single-center, randomized, parallel control clinical trial, patients will be randomly assigned to two groups. The treatment group receives ultrasound-guided erector spinae plane block with routine treatment of Acute Gastrointestinal Injury (AGI) for 7 days or until transferred to the general ward, while the control group only receives routine treatment of AGI. The primary outcome is the cure and remission rate of AGI.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, 510280, China

About this study

Detailed Description:

Study title: The treatment of Acute Gastrointestinal Injury via ultrasound-guided erector spinae plane block - a prospective, single-center, randomized, controlled trial

Principal Investigator: Professor Wang Hua, Department of Critical Care Unit, Zhujiang Hospital of Southern Medical University

Study subjects: Patients age from 18 to 80 with AGI Ⅱ or greater

Study phase: Investigator Initiated Trial(IIT)

Primary objectives:

To evaluate whether ultrasound-guided erector spinae plane block can reduce the grade of AGI , and improve the cure and remission rate of AGI.

Experimental Group:

On the basis of routine clinical treatment, the ultrasound-guided erector spinae plane block intervention is given. On the first day enrolled, patients are performed with ultrasound-guided erector spinae plane block and cannula will be placed on T8 bilaterally. 0.375% ropivacaine of 20ml is injected separately to both sides with 2ml per hour. Injection is performed twice a day for 7 days or until transferred to the general ward.

Controlled Group:

The patients will receive the clinical routine treatment according of AGI recommended by the 2012 European Society of Critical Care Medicine guidelines, with a uniform nutritional strategy(gastrointestinal dynamic drugs, traditional Chinese drugs and physical rehabilitation therapy).

Course: 7 days Sample size: 100 Sites: 1

Primary endpoints:

  • the cure rate of AGI
  • the remission rate of AGI

Secondary endpoints:

  • critical ill scores
  • Gastrointestinal function indicators
  • The inflammatory indicators
  • the lactic acid(Lac)
  • cross-sectional area of pyloric antrum(AS) with ultrasound
  • width of the colons with abdominal X ray or CT
  • the 28-day mortality
  • gastrointestinal dysfunction and duration (GIF)

Additional endpoints:

  • The length of stay in ICU
  • The total days of hospitalization

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • AGI are diagnosed according to the diagnostic criteria proposed by European Society Intensive Care Medicine (ESICM) in 2012 and the AGI grade great than or equal to II.
  • Age 18-80 years.
  • Expected length of stay longer than 3 days.

Exclusion criteria

  • Mean arterial pressure is still less than 65 millimeter of Mercury (mmHg) treated with rehydration and vasoactive agents, or with the dosage of norepinephrine more than 0.5ug/kg/min.
  • Heart rates are less than 50 beats per minute or moderate and severe atrioventricular block without pacemaker.
  • Primary gastrointestinal disease such as mechanical intestinal obstruction, massive hemorrhage of gastrointestinal tract and gastrointestinal perforation.
  • Severe trauma of chest, abdomen or back. gastrointestinal tract surgery history.
  • Neuromuscular disorders.
  • Drug addiction, alcohol abuse, opioid or amphetamine dependence, or mental disorders.
  • Pregnancy.
  • Brain dead.
  • Malignant tumor, or end-stage cachexia.
  • With contraindications of the erector spinae plane block (ESPB), such as local infection, Spinal diseases or immobilization.
  • Allergy to local anesthetics.
  • Significant abnormalities in blood coagulation parameters.
  • Without written informed consent.

Treatment and study plan

Ropivacaine injection

Drug

On the first day of inclusion, performed T8 bilateral ultrasound-guided erector spinae plane block and indwelling tube will be left + 0.375% ropivacaine 20ml to both sides. Patients will be given injections every 12 h for 7 days.

Other names: ropivacaine

Primary outcomes

  1. the cure rate of AGI

    Time frame: on the day3

    the cure rate of AGI on the day3

  2. the cure rate of AGI

    Time frame: on the day7

    the cure rate of AGI on the day7

  3. the remission rate of AGI

    Time frame: on the day3

    the remission rate of AGI on the day3

  4. the remission rate of AGI

    Time frame: on the day7

    the remission rate of AGI on the day7

Secondary outcomes

  1. Acute Physiology and Chronic Health Evaluation(APACHE II)

    Time frame: on the day 0,1,3 and 7

    measuring endpoints include:

    body temperature

    mean arterial pressure (MAP)

    heart rate (HR)

    respiratory rate (RR)

    fraction of inspiration O2 (FIO2)

    potential of hydrogen (PH)

    Na+

    K+

    serum creatinine (SCr)

    hematocrit (Hct%)

    white blood cell (WBC)

    Age

    immunosuppression before/after surgery or serious organ dysfunction

    (Higher score means a worse outcome.)

  2. Organ dysfunction assessed by Sequential Organ Failure Assessment (SOFA) score

    Time frame: on the day 0,1,3 and 7

    SOFA score evaluate status of the following organ systems separately:

    (Higher score means a worse outcome.)

    • Respiration Partial Pressure of Oxygen/Fraction of Inspiration O2 (PaO2/FiO2)
    • Coagulation Platelets
    • Liver Bilirubin
    • Circulatory Mean arterial pressure
    • Central Nervous System Glasgow coma score
    • Renal Creatinine (or urine output)
  3. the intraperitoneal pressure(IAP)

    Time frame: on the day 0,1,3 and 7

    Gastrointestinal function indicators

  4. abdominal perfusion pressure(AAP)

    Time frame: on the day 0,1,3 and 7

    Gastrointestinal function indicators

  5. total gastric residual volume(GRVs)

    Time frame: on the day 0,1,3 and 7

    Gastrointestinal function indicators

  6. feeding dose

    Time frame: on the day 0,1,3 and 7

    Gastrointestinal function indicators

  7. Gastrointestinal dysfunction and duration(GIF)

    Time frame: on the day 0,1,3 and 7

    • fasting(score 1 point)
    • reflux(score 2 points)
    • gastrointestinal decompression(1 point)
    • Gastric retention(2 points)
    • abdominal distension(2 points)
    • abdominal pain(2 points)
    • diarrhea(2 points)
    • hypoactive bowel sounds(1 point)
    • bowel sounds disappear(2 points)
    • constipation(2 points)

    The mentioned indicators will be combined to report GIF in score.

    Grade 0 (Normal) : 0 score

    Grade 1 (Mild) : 1~4 score

    Grade 2 (Medium) : 5~9 score

    Grade 3 (Serious) : >10 score

  8. Width of the colons

    Time frame: on the day 0,1,3 and 7

    width of the right colons with abdominal X ray or CT

  9. White Blood Cell(WBC)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  10. Interleukin-6(IL-6)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  11. Cross-sectional area of pyloric antrum(AS)

    Time frame: on the day 0,1,3 and 7

    cross-sectional area of pyloric antrum(AS) with ultrasound

  12. Lymphocyte (LYM)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  13. Neutral Granular Cell(NEUT)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  14. Procalcitonin (PCT)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  15. Hypersensitive C Reactive Protein(HSCRP)

    Time frame: on the day 0,1,3 and 7

    The inflammatory indicators

  16. The lactic acid(Lac)

    Time frame: on the day 0,1,3 and 7

    the serum level of the lactic

  17. The 28-day mortality

    Time frame: From enrolled to 28 days or the termination date

    the 28-day mortality

  18. The length of stay in ICU

    Time frame: on the day 28 or through study completion

    From the date of ICU admission to transfered out.

  19. The total days of hospitalization

    Time frame: on the day 28 or through study completion

    from hospital admission to hospital discharge.

Sponsors and collaborators

Lead sponsor

Zhujiang Hospital

Other

Registry information

Official study title

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block - a Prospective, Single-center, Randomized, Controlled Trial

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jun 22, 2021
Registry last updated
Sep 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.